Search Results for: RB1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
SP3 Sp3 transcription factor
  • SUMOylation of transcription factors
SPI1 Spi-1 proto-oncogene
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
  • Acute myeloid leukemia (AML)
SPIB Spi-B transcription factor
STAT3 signal transducer and activator of transcription 3
  • Interleukin-6 signaling
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Interleukin-7 signaling
  • Interleukin-7 signaling
  • Signaling by SCF-KIT
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • Signalling to STAT3
  • Signaling by ALK
  • Senescence-Associated Secretory Phenotype (SASP)
  • Signaling by Leptin
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Association of TriC/CCT with target proteins during biosynthesis
  • Transcriptional regulation of pluripotent stem cells
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • PTK6 Activates STAT3
  • PTK6 Activates STAT3
  • Interleukin-20 family signaling
  • MET activates STAT3
  • MET activates STAT3
  • Interleukin-15 signaling
  • Interleukin-35 Signalling
  • Interleukin-9 signaling
  • Interleukin-37 signaling
  • Interleukin-23 signaling
  • Interleukin-23 signaling
  • Interleukin-27 signaling
  • Interleukin-21 signaling
  • Transcriptional regulation of granulopoiesis
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF1 (M-CSF) in myeloid cells
  • STAT3 nuclear events downstream of ALK signaling
  • Inactivation of CSF3 (G-CSF) signaling
  • Cytoprotection by HMOX1
  • Signaling by ALK fusions and activated point mutants
  • Nuclear events stimulated by ALK signaling in cancer
  • Growth hormone receptor signaling
  • PKR-mediated signaling
  • Regulation of PD-L1(CD274) transcription
  • ENMD-1198
  • OPB-111077
  • Oral cancer
  • Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
STX17 syntaxin 17
  • COPII-mediated vesicle transport
SUV39H1 SUV39H1 histone lysine methyltransferase
  • PKMTs methylate histone lysines
  • SIRT1 negatively regulates rRNA expression
TAF1 TATA-box binding protein associated factor 1
  • HIV Transcription Initiation
  • RNA Polymerase II HIV Promoter Escape
  • Transcription of the HIV genome
  • RNA Polymerase II Pre-transcription Events
  • Regulation of TP53 Activity through Phosphorylation
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
TASOR transcription activation suppressor
  • Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
  • Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
TBP TATA-box binding protein
  • HIV Transcription Initiation
  • RNA Polymerase II HIV Promoter Escape
  • Transcription of the HIV genome
  • SIRT1 negatively regulates rRNA expression
  • NoRC negatively regulates rRNA expression
  • B-WICH complex positively regulates rRNA expression
  • RNA Polymerase II Pre-transcription Events
  • Regulation of TP53 Activity through Phosphorylation
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Transcription Termination
  • RNA Polymerase III Abortive And Retractive Initiation
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase III Transcription Initiation From Type 3 Promoter
  • RNA Polymerase III Transcription Initiation From Type 3 Promoter
  • Estrogen-dependent gene expression
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
TFAP2A transcription factor AP-2 alpha
  • Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • TFAP2 (AP-2) family regulates transcription of other transcription factors
  • Activation of the TFAP2 (AP-2) family of transcription factors
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • TFAP2 (AP-2) family regulates transcription of cell cycle factors
  • TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
  • Positive Regulation of CDH1 Gene Transcription
  • Regulation of MITF-M-dependent genes involved in pigmentation
  • Specification of the neural plate border
  • Specification of the neural plate border
  • Developmental Lineage of Mammary Stem Cells
  • Branchiooculofacial syndrome (BOFS)
TGM2 transglutaminase 2
  • Guanosine-5'-Diphosphate
  • Hexylresorcinol
THOC1 THO complex subunit 1
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • mRNA 3'-end processing
  • RNA Polymerase II Transcription Termination
TMPO thymopoietin
  • RHOA GTPase cycle
  • RHOC GTPase cycle
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOG GTPase cycle
  • RHOJ GTPase cycle
  • RAC3 GTPase cycle
  • RHOF GTPase cycle
TOP2A DNA topoisomerase II alpha
  • Transcription of E2F targets under negative control by DREAM complex
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • Moxifloxacin
  • Amsacrine
  • Dexrazoxane
  • Valrubicin
  • Teniposide
  • Epirubicin
  • Enoxacin
  • Pefloxacin
  • Ciprofloxacin
  • Trovafloxacin
  • Daunorubicin
  • Etoposide
  • Dactinomycin
  • Lomefloxacin
  • Doxorubicin
  • Norfloxacin
  • Norfloxacin
  • Ofloxacin
  • Idarubicin
  • Podofilox
  • Mitoxantrone
  • Sparfloxacin
  • Genistein
  • Fleroxacin
  • Lucanthone
  • Banoxantrone
  • SP1049C
  • Amonafide
  • Elsamitrucin
  • 13-deoxydoxorubicin
  • RTA 744
  • Aldoxorubicin
  • ZEN-012
  • Amrubicin
  • Becatecarin
  • Annamycin
  • Declopramide
  • Finafloxacin
TRAP1 TNF receptor associated protein 1
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
TRIM27 tripartite motif containing 27
  • SUMOylation of ubiquitinylation proteins
  • Regulation of PTEN stability and activity
  • Suppression of apoptosis
TRIM28 tripartite motif containing 28
  • Generic Transcription Pathway
  • SUMOylation of transcription cofactors
  • HCMV Early Events
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
TRIP11 thyroid hormone receptor interactor 11
  • Intraflagellar transport
  • Intra-Golgi traffic
  • Signaling by FLT3 fusion proteins
  • Signaling by FLT3 fusion proteins
  • Achodrogenesis type IA
TRMO tRNA methyltransferase O
UBE2I ubiquitin conjugating enzyme E2 I
  • Meiotic synapsis
  • Vitamin D (calciferol) metabolism
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of transcription factors
  • SUMOylation of transcription factors
  • SUMOylation of ubiquitinylation proteins
  • SUMOylation of transcription cofactors
  • SUMOylation of transcription cofactors
  • SUMOylation of SUMOylation proteins
  • SUMOylation of intracellular receptors
  • SUMOylation of intracellular receptors
  • SUMOylation of chromatin organization proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA methylation proteins
  • SUMOylation of DNA methylation proteins
  • SUMOylation of immune response proteins
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Processing of DNA double-strand break ends
  • Formation of Incision Complex in GG-NER
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Postmitotic nuclear pore complex (NPC) reformation
  • Maturation of nucleoprotein
  • Maturation of nucleoprotein
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SUMOylation of nuclear envelope proteins
  • PKR-mediated signaling
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Transcriptional and post-translational regulation of MITF-M expression and activity

Page 20 out of 21 pages